XML 52 R42.htm IDEA: XBRL DOCUMENT v3.22.4

Note 17 – Warrants (Tables)

9 Months Ended

Jan. 31, 2023

Note 17 Warrants

[custom:ScheduleOfStockholdersEquityNoteWarrantsOrRights1TextBlock]

				Upon Issuance								Outstanding at January 31, 2022
Date of Transaction				Number of Warrants				Initial Fair Value				Number of Warrants				Fair Value
	October 2020				399,998			$	267,999				266,666			$	273,196
	January 2021				675,000			$	2,870,666				540,000			$	582,904

Defined Benefit Plan, Assumptions [Table Text Block]

			2023				2022
Risk-free interest rate			—				0.79 – 0.85%
Expected dividend yield			—				—
Expected term (in years)			—				5.00
Expected volatility			—				222.45 – 223.17%

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

				Number of Shares			Weighted-average Exercise Price per Share				Weighted-average Remaining Contractual Term (in years)				Aggregate Intrinsic Value
	Balance as of April 30, 2021			873,332				1.50				4.62			$	2,218,263
	Granted			733,333			$	5.45
	Exercised			(66,666	)			1.50
	Outstanding as of April 30, 2022			1,539,999				3.38				3.89			$	427,533
	Granted			—
	Exercised			—
	Outstanding at January 31, 2022			1,539,999			$	3.38				3.13			$	—

X

- References

No definition available.

+ Details

Name:	RCAT_DisclosureNote17WarrantsAbstract
Namespace Prefix:	RCAT_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	RCAT_ScheduleOfStockholdersEquityNoteWarrantsOrRights1TextBlock
Namespace Prefix:	RCAT_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (k)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

+ Details

Name:	us-gaap_ScheduleOfAssumptionsUsedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration